Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Stomach Neoplasms 11Esophageal Neoplasms 8Barrett Esophagus 6Gastrointestinal Neoplasms 5Rectal Neoplasms 3Colonic Neoplasms 3Precancerous Conditions 2Lung Neoplasms 2Hemorrhage 2Gastric GIST 2Esophageal Squamous Cell Carcinoma 2Colonic Polyps 2Carcinoma, Non-Small-Cell Lung 2Adenoma 2Adenocarcinoma Of Esophagus 2Tobacco Use Disorder 1Submucosal Tumor of Stomach 1Small Size Gastrointestinal Stromal Tumors 1Small Cell Lung Carcinoma 1Rectal Neuroendocrine Tumors 1Polyps 1Pituitary Neoplasms 1Personal Satisfaction 1Pathological Conditions, Anatomical 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Glandular and Epithelial 1

Interventions

Radiotherapy 2Oxaliplatin 2sintilimab 1irinotecan sucrosofate 1dostarlimab 1XELOX 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Endoscopic Mucosal Resection 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Rectal Cancer (LARC) × Endoscopic Mucosal Resection × Clear all
NCT06761287 2025-05-30

OPAL

Centre Hospitalier Universitaire Saint Pierre

Phase NA Recruiting
20 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡